Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
NCT00476034
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1312
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
Interventions
DRUG:
lumiracoxib
Sponsor
Novartis